Global Patient Services at Sheba Medical Center-Tel Hashomer shared a post on LinkedIn:
“We are proud to share that Jacob Schachter, one of Israel’s leading oncologists specializing in melanoma, has received a Lifetime Achievement Award from the Israeli Society for Clinical Oncology and Radiation Therapy, in recognition of his long-standing contribution to the field.
Among Prof. Schachter’s key contributions are:
- The establishment of the Ella Lemelbaum Institute for Melanoma and Immunotherapy in 2004
- Leading one of the world’s most advanced and innovative clinical and research programs for melanoma and skin cancer
- Playing a central role in the design and execution of pioneering clinical trials in melanoma
- Significant contribution to the development of novel therapeutic approaches, with a particular emphasis on immunotherapy
- Extensive publication record, including dozens of articles in leading international peer-reviewed medical journals
- Presentation of key research findings at major international scientific conferences
Over decades of leadership, research, and clinical innovation, Prof. Schachter has profoundly shaped the field of melanoma care and continues to improve patients outcomes in Israel and around the world.”
Mika Amram, Director of Global Patient Services at Sheba Medical Center-Tel Hashomer, shared this post, adding:
“After years of dedication to advancing melanoma research and patient care, Jacob Schachter’s leadership and contributions, including the founding of the Ella Lemelbaum Institute for Melanoma and Immunotherapy at Sheba’s Jusidman Cancer Center, make this recognition especially meaningful.
Congratulations on this well-earned honor, and thank you for your long standing commitment to advancing cancer care at Sheba Medical Center, Tel Hashomer.”
More posts featuring Jacob Schachter.